Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Simple exercises may restore shoulder function after breast cancer surgery

NCT ID NCT07478718

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether a specific set of shoulder and scapular exercises can reduce pain, improve range of motion, and lessen disability in women who have had a mastectomy. 33 women aged 30-65, 4-12 weeks post-surgery, will be randomly assigned to either the exercise program or standard care. The goal is to prevent long-term shoulder problems and improve quality of life.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 33 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Apr 2026

An estimate. Start dates often move.

Expected to finish

Aug 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

30 to 65 years

Sex

Female participants only

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Participants must meet all of the following criteria: 1. Female adults between 30 and 65 years old. 2. History of unilateral breast cancer managed with either: * Modified radical mastectomy, or * Breast-conserving surgery with axillary clearance. 3. Postoperative interval between 4 and 12 weeks before enrollment. 4. Objective evidence of impaired shoulder mobility or function including: * Reduction of ROM ≥ 15% compared to the contralateral side, * VAS pain ≥ 3/10 during shoulder movement, or * DASH functional score \> 25. 5. Ability to ambulate independently and follow therapist instructions. 6. Willingness to commit to the full rehabilitation protocol for 8 weeks. Exclusion Criteria: * Participants will be excluded if they have: * Previously diagnosed shoulder disorders (adhesive capsulitis, rotator cuff tear, fracture/dislocation). * Active or untreated lymphedema Grade II-III. * Ongoing chemotherapy-induced neuropathy causing shoulder dysfunction. * History of neurological or rheumatological disorders affecting the upper limb. * Metastatic disease or local recurrence. * Recent infection, seroma, or unhealed surgical wounds. * Participation in another physical therapy or exercise program in the past 4 weeks. * Cognitive impairment or psychiatric conditions interfering with adherence.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Breast cancer are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Hany elgohary

    Jerash, 22B, Jordan

More trials for these conditions

Other studies related to the condition(s) this trial covers.